Philips is one of the leaders in imaging and image-guided therapies. But the company's track record is checkered, with multiple self-induced missteps tarnishing its reputation and investor confidence. We believe the resolution of sleep care problems, focus on its high-performing areas, and new management team should be able to change the narrative, but uncertainty remains.
Philips is the first to market with its helium-free 3.0T MR, which should help it recover some market share losses following its supply chain issues.
China's return to prominence is highly uncertain. Philips has an outsize exposure to this market, both in imaging and personal health.
|
Metric
|
PHG
|
RMD
|
SHL
|
|---|---|---|---|
Price/Earnings (Normalized) | 14.73 | 17.15 | 15.27 |
Price/Book Value | 1.93 | 4.28 | 2.13 |
Price/Sales | 1.25 | 4.89 | 1.69 |
Price/Cash Flow | 9.02 | 14.27 | 12.45 |
|
Metric
|
PHG
|
RMD
|
SHL
|
|---|---|---|---|
Quick Ratio | 0.79 | 2.00 | 0.66 |
Current Ratio | 1.32 | 3.01 | 1.04 |
Interest Coverage | 4.98 | — | 7.67 |
|
Metric
|
PHG
|
RMD
|
SHL
|
|---|---|---|---|
Return on Assets (Normalized) | 5.57% | 19.09% | — |
Return on Equity (Normalized) | 13.59% | 25.91% | — |
Return on Invested Capital (Normalized) | 8.67% | 22.35% | — |
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Knkyqwn | Nzpcskn | $154B | |||
| Stryker Corp
SYK
| Pbnmqnlhnb | Mlkd | $120B | |||
| Medtronic PLC
MDT
| Xlsvywqy | Tcxnhkw | $103B | |||
| Boston Scientific Corp
BSX
| Hfptmkx | Kpmgyh | $70B | |||
| Edwards Lifesciences Corp
EW
| Vhgtkzxw | Yxrgyj | $49B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| Nbdqpdsk | Hjpmx | $30B | |||
| DexCom Inc
DXCM
| Shpfvxgx | Kbcgzls | $29B | |||
| Steris PLC
STE
| Rgfvzngj | Pqrmbp | $20B | |||
| Zimmer Biomet Holdings Inc
ZBH
| Dhzzpnnfw | Bmpt | $17B |
United States